Bio-Rad Laboratories, Inc. BIO.B EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories, Inc.'s EPS (diluted)?
- Bio-Rad Laboratories, Inc. (BIO.B) reported EPS (diluted) of -$19.55 in Q1 2026.
- How has Bio-Rad Laboratories, Inc.'s EPS (diluted) changed year-over-year?
- Bio-Rad Laboratories, Inc.'s EPS (diluted) decreased by 953.7% year-over-year, from $2.29 to -$19.55.
- What is the long-term trend for Bio-Rad Laboratories, Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories, Inc.'s EPS (diluted) has grown at a -33.4% compound annual growth rate (CAGR), from $140.35 to $27.65.
- What does EPS (diluted) mean?
- The profit per share assuming all potential dilutive securities are converted into common stock.
- How do you interpret EPS (diluted)?
- A narrowing gap between basic and diluted EPS indicates a lower risk of future dilution, while a wide gap suggests significant outstanding dilutive instruments.
- How does EPS (diluted) compare across companies?
- The primary metric used by analysts for valuation; peers with complex capital structures often show significant differences between basic and diluted EPS.